Co-Diagnostics, Inc. (CODX)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.4500 |
| Open | 1.4400 |
| Bid | 1.3700 x 1100 |
| Ask | 1.4300 x 800 |
| Day's Range | 1.3500 - 1.5180 |
| 52 Week Range | 1.3500 - 7.1300 |
| Volume | |
| Avg. Volume | 134,065 |
| Market Cap | 42.976M |
| Beta (5Y Monthly) | -0.46 |
| PE Ratio (TTM) | 0.91 |
| EPS (TTM) | 1.5200 |
| Earnings Date | May 10, 2023 - May 15, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.67 |
- Simply Wall St.
Co-Diagnostics (NASDAQ:CODX shareholders incur further losses as stock declines 45% this week, taking three-year losses to 83%
As every investor would know, not every swing hits the sweet spot. But really bad investments should be rare. So take a...
- PR Newswire
Co-Diagnostics, Inc. to CEO to Deliver Keynote Address at 2023 MarketsandMarkets Conference in London, England
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company CEO will deliver the keynote address at the 4th Annual MarketsandMarkets Infectious Disease Diagnostics and Molecular Diagnostics Conference, held March 23-24, 2023, in London, England, where the Company will also be hosting a booth.
- Insider Monkey
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2022 Earnings Call Transcript March 16, 2023 Operator: Good afternoon, and welcome to the Co-Diagnostics, Inc. Fourth Quarter and Full Year 2022 Earnings Results Conference Call. All participants will be in a listen-only mode. After today’s presentation, there will be an opportunity to ask questions. Please note that this event is […]
